Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 02, 2026
TickeronGET DAILY SIGNALS
Ichor Holdings (ICHR) Delivers Strong Q3 Turnaround with Revenue Up +37%

Ichor Holdings (ICHR) Delivers Strong Q3 Turnaround with Revenue Up +37%

Key Takeaways

  • Revenue rose to $328.7 million, up 37% year over year and 12% from the prior quarter.
  • The company swung to a GAAP net income of $20.9 million, versus a $22.9 million net loss in the same period a year earlier.
  • Non-GAAP diluted earnings per share (EPS) came in at $0.63, beating the consensus estimate of $0.45 by $0.18.
  • Gross margin expanded to 15.8%, up from 13.9% in the prior quarter, helped by a higher-margin product mix.
  • Free cash flow was negative $39.5 million, as rising inventory and receivables absorbed cash.
  • Fourth-quarter guidance calls for revenue of $345 million to $365 million and non-GAAP diluted EPS of $0.65 to $0.75.

What This Earnings Report Means for Investors

Ichor Holdings, Ltd. designs and manufactures gas and chemical delivery subsystems and precision components used in semiconductor capital equipment, so its results serve as a real-time gauge of chip-equipment demand. The fiscal third quarter of 2026 marks a pivotal moment: after a deep downturn, revenue has now climbed roughly 50% from its recent trough in just three quarters, and profitability has returned. For investors, this report tests whether ICHR's operating-leverage story can convert accelerating wafer fab equipment (WFE) spending into durable earnings. Because the company carries heavy fixed costs, even modest volume gains flow through strongly to margins, making quarterly results a key signal on both its own execution and the health of the broader semiconductor supply chain. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Reported Results

For the third quarter of fiscal 2026, ended September 25, 2026, Ichor reported net sales of $328.7 million, an increase of 37% year over year and 12% sequentially from $294.8 million in the prior quarter. Net sales came in slightly below the consensus estimate of about $330 million.

On the bottom line, the company reported GAAP net income of $20.9 million, a sharp reversal from a $22.9 million net loss a year earlier. Non-GAAP diluted EPS, which excludes certain one-time items, reached $0.63, well above the consensus forecast of $0.45.

Gross margin improved to 15.8%, up from 13.9% in the prior quarter, reflecting a shift toward higher-margin component sales and increased proprietary content. Operating margin also expanded materially, supported by disciplined operating expenses. The key offset was cash flow: free cash flow was negative $39.5 million, as inventory and accounts receivable grew faster than sales.

Market Reaction and Investor Sentiment

Shares of ICHR rose about 3% in early after-hours trading following the release, as investors weighed a strong profit beat against a slight revenue miss and ongoing cash burn. The market appeared to focus on the sharp margin expansion and the return to profitability, which validated the company's restructuring efforts and its shift toward higher-margin proprietary content. Sentiment also benefited from fourth-quarter guidance that points to continued sequential growth in revenue, gross margin, and EPS. However, the negative free cash flow and rising working capital remained notable concerns, reflecting the cost of a supplier scaling up to meet a steep demand ramp.

Forward Outlook and Key Factors to Monitor

Looking ahead, Ichor guided to fourth-quarter revenue of $345 million to $365 million and non-GAAP diluted EPS of $0.65 to $0.75, implying continued sequential growth and full-year 2026 revenue growth of roughly 30%. Management has signaled that demand visibility extends well into 2027, supported by a robust WFE spending environment.

Investors should watch whether gross margin continues to climb toward the company's near-term 15% target and its longer-term 20% goal. The pace of proprietary-content adoption and the successful ramp of manufacturing-site realignment efforts will be central to sustaining that expansion.

On the other side of the ledger, cash generation remains a key watch item. Inventory and receivables have been absorbing significant cash, and management has indicated positive operating cash flow may not return until the first half of 2027. Supply-chain constraints in high-end etch and deposition segments could also temper the growth trajectory.

Finally, cost discipline and any shift in end-market demand—particularly in areas such as silicon carbide and European or lithography demand—will influence whether ICHR can keep converting revenue growth into accelerating earnings. From what I see, these elements will determine how sustainable the recovery proves to be.

Integrating AI Tools into Earnings Analysis

In my own research process, I often turn to Tickeron’s AI Screener to quickly filter semiconductor names by fundamentals, margin trends, and recent performance. It helps surface comparable companies and highlight patterns that might otherwise take hours to identify manually. This kind of tool complements traditional earnings review by adding speed and breadth without replacing careful fundamental work.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ICHR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for ICHR turns negative, indicating new downward trend

ICHR saw its Momentum Indicator move below the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 76 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 39 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

ICHR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

The 50-day moving average for ICHR moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for ICHR entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for ICHR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +13.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 253 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.594) is normal, around the industry mean (6.211). P/E Ratio (-31.487) is within average values for comparable stocks, (81.436). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ICHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 50.95B. The market cap for tickers in the group ranges from 326.86K to 665.22B. ASMLF holds the highest valuation in this group at 665.22B. The lowest valued company is AVSR at 326.86K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -5%. For the same Industry, the average monthly price growth was -30%, and the average quarterly price growth was -36%. ATOM experienced the highest price growth at 12%, while SMTK experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 15%. For the same stocks of the Industry, the average monthly volume growth was 66% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 44
Price Growth Rating: 63
SMR Rating: 71
Profit Risk Rating: 75
Seasonality Score: 29 (-100 ... +100)
View a ticker or compare two or three
ICHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment

Industry ElectronicProductionEquipment

Industry
Semiconductors
Address
3185 Laurelview Court
Phone
+1 510 897-5200
Employees
2448
Web
https://www.ichorsystems.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.
Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.